IL111044A - Use of an combination of an anti-inflammatory compound and an analgesic compound for the manufacture of anti-podagra drugs - Google Patents

Use of an combination of an anti-inflammatory compound and an analgesic compound for the manufacture of anti-podagra drugs

Info

Publication number
IL111044A
IL111044A IL11104494A IL11104494A IL111044A IL 111044 A IL111044 A IL 111044A IL 11104494 A IL11104494 A IL 11104494A IL 11104494 A IL11104494 A IL 11104494A IL 111044 A IL111044 A IL 111044A
Authority
IL
Israel
Prior art keywords
ibuprofen
indomethacin
codeine
dextropropoxyphene
morphine
Prior art date
Application number
IL11104494A
Other languages
English (en)
Hebrew (he)
Other versions
IL111044A0 (en
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of IL111044A0 publication Critical patent/IL111044A0/xx
Publication of IL111044A publication Critical patent/IL111044A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11104494A 1993-09-22 1994-09-22 Use of an combination of an anti-inflammatory compound and an analgesic compound for the manufacture of anti-podagra drugs IL111044A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939319568A GB9319568D0 (en) 1993-09-22 1993-09-22 Pharmaceutical compositions and usages

Publications (2)

Publication Number Publication Date
IL111044A0 IL111044A0 (en) 1994-12-29
IL111044A true IL111044A (en) 1998-12-06

Family

ID=10742359

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11104494A IL111044A (en) 1993-09-22 1994-09-22 Use of an combination of an anti-inflammatory compound and an analgesic compound for the manufacture of anti-podagra drugs

Country Status (10)

Country Link
US (2) US5763452A (zh)
EP (1) EP0649657A1 (zh)
JP (1) JPH07330628A (zh)
CN (1) CN1078071C (zh)
AU (1) AU7414694A (zh)
CA (1) CA2132568A1 (zh)
GB (1) GB9319568D0 (zh)
IL (1) IL111044A (zh)
NO (1) NO306235B1 (zh)
ZA (1) ZA947305B (zh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19607395C2 (de) * 1996-02-28 2002-11-21 Lohmann Therapie Syst Lts Salze aus einem kationischen narkotischen Analgetikum mit einem anionischen nichtnarkotischen Analgetikum, Verfahren zu deren Herstellung und die diese Salze enthaltenden pharmazeutischen Präparate
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6228863B1 (en) * 1997-12-22 2001-05-08 Euro-Celtique S.A. Method of preventing abuse of opioid dosage forms
RS50070B (sr) 1997-12-22 2009-01-22 Euro-Celtique S.A., Oralni dozni oblik sa kombinacijom opijatnog agonista i antagonista
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
EP1126826B3 (en) * 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
JP2003522146A (ja) * 2000-02-08 2003-07-22 ユーロ−セルティーク，エス．エイ． 外圧に抵抗性の経口オピオイドアゴニスト製剤
ATE493130T1 (de) 2001-05-11 2011-01-15 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
DK1416842T3 (da) * 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
NZ530971A (en) 2001-08-06 2004-08-27 Euro Celtique S Oral dosage forms comprising an opioid agonist with releasable and sequestered opioid antagonists
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
KR20030060730A (ko) * 2002-01-09 2003-07-16 하나제약 주식회사 난용성 약물의 서방화 제제 조성물
EP1492505B1 (en) 2002-04-05 2015-06-03 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
EP1505976B1 (en) * 2002-05-16 2007-12-12 N.V. Organon Synergistic combination of an opioid analgesic and a nsaid
AU2003270778B2 (en) 2002-09-20 2009-10-08 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
TW200500067A (en) * 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
SE0301880D0 (sv) * 2003-06-25 2003-06-25 Astrazeneca Uk Ltd New drug delivery composition
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
JP2008542219A (ja) * 2005-05-25 2008-11-27 インゲニウム ファーマシューティカルズ ジーエムビーエイチ 疼痛処置法
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US20100010029A1 (en) * 2006-05-03 2010-01-14 Kowa Phamaceuticals America, Inc. Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations
EP1859771A1 (en) * 2006-05-24 2007-11-28 Guardant S.r.l. Low-compatible active principles in bipartite bag
PT2034975E (pt) 2006-06-19 2012-06-25 Alpharma Pharmaceuticals Llc Composições farmacêuticas
US20080075771A1 (en) * 2006-07-21 2008-03-27 Vaughn Jason M Hydrophilic opioid abuse deterrent delivery system using opioid antagonists
GB0625646D0 (en) * 2006-12-21 2007-01-31 Jagotec Ag Improvements in or relating to organic compounds
US20080226734A1 (en) * 2007-03-16 2008-09-18 Elan Corporation Plc Combination of a narcotic and non-narcotic analgesic
WO2008129069A1 (en) * 2007-04-24 2008-10-30 Ingenium Pharmaceuticals Gmbh Inhibitors of protein kinases
JP5566880B2 (ja) 2007-04-24 2014-08-06 インゲニウム ファーマシューティカルズ ジーエムビーエイチ プロテインキナーゼの阻害剤としての４，６−二置換アミノピリミジン誘導体
ES2539518T3 (es) * 2007-04-24 2015-07-01 Astrazeneca Ab Inhibidores de proteínas quinasas
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8362029B2 (en) 2008-12-31 2013-01-29 Upsher-Smith Laboratories, Inc. Opioid-containing oral pharmaceutical compositions and methods
LT2405915T (lt) 2009-03-10 2019-03-12 Euro-Celtique S.A. Greito atpalaidavimo farmacinė kompozicija, apimanti oksikodoną ir naloksoną
BR112012008317A2 (pt) 2009-09-17 2016-03-22 Upsher Smith Lab Inc produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012513A (en) * 1971-11-03 1977-03-15 Imperial Chemical Industries Limited Indole derivatives for providing analgesic and anti-inflammatory effects
US4183941A (en) * 1978-08-21 1980-01-15 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
US5763452A (en) 1998-06-09
NO943511D0 (no) 1994-09-21
IL111044A0 (en) 1994-12-29
CN1108934A (zh) 1995-09-27
US5908848A (en) 1999-06-01
AU7414694A (en) 1995-04-06
CN1078071C (zh) 2002-01-23
EP0649657A1 (en) 1995-04-26
NO306235B1 (no) 1999-10-11
JPH07330628A (ja) 1995-12-19
CA2132568A1 (en) 1995-03-23
GB9319568D0 (en) 1993-11-10
ZA947305B (en) 1995-05-10
NO943511L (no) 1995-03-23

Similar Documents

Publication Publication Date Title
US5908848A (en) Synergistic composition of codine and ibuprofen to treat arthritis
RU2125873C1 (ru) Болеутоляющая композиция и способ достижения болеутоляющего эффекта у человека
EP0255404B1 (en) Sustained release ibuprofen formulation
EP0316434A1 (en) Cough and cold mixtures comprising antihistamine drugs without sedative effects.
WO1988008302A1 (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
CA2079642A1 (en) Medicament
EP0346431A1 (en) Onset-hastened/enhanced analgesia using s(+) ketoprofen
CN1391470A (zh) 治疗炎症的药物组合及其方法
US4420483A (en) Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US20120064152A1 (en) Analgesic and Anti-Inflammatory Compositions Comprising Domperidone and Methods of Using Same
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
AU3806393A (en) Antipyretic and analgesic methods and compositions containing optically pure r-etodolac
JPH05500361A (ja) 開始―促進され／増強された解熱応答
CA2476939A1 (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
NZ252132A (en) Rectal medicaments containing a 5ht1 receptor agonist (eg certain indole-5-sulphonamide derivatives) and a hard fat base carrier with a hydroxyl value > 15
JP2017171626A (ja) プロピオン酸系非ステロイド性消炎鎮痛薬を含有した医薬組成物
EP1605929B1 (en) Non-steroidal anti-inflammatory drug dosing regimen
KR890014110A (ko) 의약제
AU662297B2 (en) Method for providing improved analgesic effect
CA2030209A1 (en) Therapeutic agents
Rhymer et al. A double-blind trial comparing indomethacin sustained release capsules (Indocid-R) with indomethacin capsules in patients with rheumatoid arthritis
US4243673A (en) Analgesic compositions and methods of use
RU2182016C2 (ru) Спазмолитическая композиция, способ получения спазмолитической композиции
US20030191188A1 (en) Method for treating migraine symptoms with ibuprofen and salts thereof
AU2013267036A1 (en) Non-steroidal anti-inflammatory drug dosing regimen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees